Streetbeat News

Earnings

TBPH

Theravance Biopharma (NASDAQ:TBPH) reported Q2 2024 adjusted EPS of $(0.13), beating the analyst estimate of $(0.21) by 38.1%. However, sales of $14.256 million missed the $15.453 million estimate by 7.75%, though they increased by 3.69% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:14 pm

AVGO

Broadcom Inc. (NASDAQ:AVGO) shares are trading lower amid a broader market sell-off driven by global economic concerns. The company is set to announce its Q3 FY2024 financial results on Sept. 5, 2024, with an estimated EPS of $1.20 and revenue of $12.955 billion. Despite mixed sentiment in the options market, analysts have issued positive ratings with a consensus target price of $1002.

Portfolio Pulse from Vaishali Prayag

August 05, 2024 | 8:14 pm

CSWC

Capital Southwest (NASDAQ:CSWC) reported Q1 2025 earnings of $0.63 per share, beating the analyst estimate of $0.58. Sales were $51.354 million, surpassing the $49.131 million estimate. Despite a year-over-year EPS decrease, sales increased significantly.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:13 pm

BMRN

Biomarin Pharmaceutical (NASDAQ:BMRN) reported Q2 2024 earnings of $0.96 per share, significantly beating the analyst estimate of $0.35. The company also reported sales of $712.03 million, surpassing the $662.05 million estimate and marking a 19.61% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:13 pm

CHGG

Chegg (NYSE:CHGG) reported Q2 2024 adjusted EPS of $0.28, beating the estimate of $0.22 by 27.27%. Sales were $163.10M, surpassing the $159.98M estimate but down 10.80% from $182.85M last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:13 pm

CSTL

Castle Biosciences (NASDAQ:CSTL) reported Q2 2024 GAAP EPS of $0.31, significantly beating the analyst estimate of $(0.28). The company also reported sales of $87.002 million, surpassing the estimate of $69.341 million and marking a 73.53% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:13 pm

GTBIF

Green Thumb Industries (OTC:GTBIF) reported Q2 2024 earnings per share (EPS) of $0.09, beating the analyst estimate of $0.05 by 80%. The company also reported sales of $280.147 million, surpassing the $277.298 million estimate. This represents an 11% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:12 pm

BCC

Boise Cascade (NYSE:BCC) reported Q2 2024 GAAP EPS of $2.84, beating the analyst estimate of $2.69 by 5.58%. The company also reported sales of $1.797 billion, surpassing the $1.771 billion estimate by 1.46%. However, this represents a 0.99% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:12 pm

PLTR

Palantir shares are trading higher after the company reported better-than-expected Q2 results.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:12 pm

AAN

Aarons (NYSE:AAN) reported Q2 2024 adjusted EPS of $(0.07), missing the $0.04 estimate by 275%. Sales were $503.125M, missing the $515.674M estimate by 2.43% and down 5.14% from last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:11 pm